Login
$OMER
$15.35 -$1.33 (8.0%) After hours

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Joined Source
Gregory A. Demopulos Also a director
President, Chief Executive Officer and Chairman of the Board of Directors
67 Since 1994
32 years
Not stated
David J. Borges
Vice President, Finance, Chief Accounting Officer and Treasurer
62 Since 2024
2 years
2020
Peter B. Cancelmo
Vice President, General Counsel and Secretary
47 Since 2019
7 years
2019

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 30, 2026 · updated by the 8-K of Aug 13, 2026

Directors
9
serving now
Independent
6 of 8
stated in the proxy; 1 not stated
Average tenure
19.2 years
from year joined
CEO also chairs the board
Yes
Gregory A. Demopulos, M.D.
Director Age On board Independent Committees Other public boards Pay Source
Gregory A. Demopulos, M.D.
67 1994
32 years
Not independent None stated Smead Funds Trust Paid as CEO
Thomas J. Cable
86 1995
31 years
Independent
Nominating and Governance · Chair
None stated Not stated
Peter A. Demopulos, M.D.
72 1995
31 years
Not independent
Scientific
None stated Not stated
Diana T. Perkinson, M.D.
72 2023
3 years
Independent
Scientific
None stated Not stated
Thomas F. Bumol, Ph.D.
72 2019
7 years
Independent
Scientific · Chair
None stated Not stated
Leroy E. Hood, M.D., Ph.D.
87 2001
25 years
Independent
Compensation
None stated Not stated
Arnold C. Hanish
78 2012
14 years
Independent
Audit · Chair
None stated Not stated
Rajiv Shah, M.D.
53 2015
11 years
Independent
Audit Compensation Scientific
None stated Not stated
Joseph Schocken Joined Aug 12, 2026
- - -
Audit Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

2 disclosed in the proxy filed Apr 30, 2026
Gregory A. Demopulos, M.D.
Amount not stated

Technology transfer agreements under which he irrevocably transferred to us his intellectual property rights in the PharmacoSurgery platform and former Chondroprotective program, with a repurchase right on certain liquidations.

Directors and executive officers
Amount not stated

Indemnification agreements providing for indemnification of expenses, judgments, fines and settlements relating to their service to the company.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support